The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
- PMID: 3906410
- DOI: 10.1038/318533a0
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Abstract
Transgenic mice bearing the cellular myc oncogene coupled to the immunoglobulin mu or kappa enhancer frequently develop a fatal lymphoma within a few months of birth. Since the tumours represent represent both immature and mature B lymphocytes, constitutive c-myc expression appears to be highly leukaemogenic at several stages of B-cell maturation. These myc mice should aid study of lymphoma development, B-cell ontogeny and immunoglobulin regulation.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials